Biomarkers
Conditions
Interventions
This is a randomized, double-blind clinical trial. A total of 20 individuals who meet the eligibility criteria will be probabilistically allocated to one of the intervention groups using a random numb
Sponsors
União Brasileira de Educação e Assistência
União Brasileira de Educação e Assistência
Eligibility
Sex/Gender
Male
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Adult male bodybuilders; age 20 to 35; who have been bodybuilding for at least six months; practitioners who include at least three weightlifting physical activity sessions per week
Exclusion criteria
Exclusion criteria: Individuals diagnosed with any chronic disease or condition such as hypertension ; type 1 or type 2 diabetes mellitus ; as well as those using dietary supplements or medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that curcumin supplementation induced muscle hypertrophy in the participants | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that the analysis will show that curcumin supplementation increased maximal strength in the participants;It is expected that the analysis will show that curcumin supplementation altered the participants' biochemical biomarkers | — |
Countries
Brazil
Contacts
Public ContactGiuseppe Stefani
Pontifícia Universidade Católica do Rio Grande do Sul
Outcome results
None listed